Article Figures & Tables
Tables
- Table 1:
Characteristics of patients with diabetes mellitus in Newfoundland and Labrador, fiscal year 2015/16
Characteristic All patients Urban Rural Standardized difference† (95% CI) No. (%)*
n = 66 325Crude prevalence, % (95% CI) No. (%)*
n = 28 969Crude prevalence, % (95% CI) No. (%)*
n = 37 356Crude prevalence, % (95% CI) Age, yr, mean ± SD 64.1 ± 13.6 NA 63.4 ± 14.1 NA 64.6 ± 13.1 NA 0.08 (0.068 to 0.098) Age group, yr 0.112 (0.097 to 0.127) 20–34 1791 (2.7) 2.10 (2.00 to 2.20) 980 (3.4) 1.78 (1.67 to 1.89) 811 (2.2) 2.67 (2.49 to 2.86) 35–49 7547 (11.4) 7.26 (7.10 to 7.43) 3628 (12.5) 6.25 (6.05 to 6.46) 3919 (10.5) 8.54 (8.27 to 8.81) 50–64 22 545 (34.0) 17.65 (17.42 to 17.88) 9867 (34.1) 16.26 (15.94 to 16.58) 12 678 (33.9) 18.91 (18.58 to 19.24) 65–79 26 267 (39.6) 32.59 (32.20 to 32.98) 10 864 (37.5) 30.80 (30.22 to 31.38) 15 403 (41.2) 33.98 (33.44 to 34.52) ≥ 80 8175 (12.3) 40.03 (39.17 to 40.90) 3630 (12.5) 37.50 (36.28 to 38.72) 4545 (12.2) 42.32 (41.09 to 43.55) Sex 0.03 (0.014 to 0.045) Male 33 451 (50.4) 16.58 (16.40 to 16.76) 14 849 (51.3) 14.25 (14.02 to 14.47) 18 602 (49.8) 19.08 (18.80 to 19.35) Female 32 874 (49.6) 15.20 (15.04 to 15.36) 14 120 (48.7) 12.34 (12.13 to 12.54) 18 754 (50.2) 18.42 (18.15 to 18.68) Case source 0.178 (0.162 to 0.193) Laboratory only 11 118 (16.8) NA 3789 (13.1) NA 7329 (19.6) NA CCDSS only 10 621 (16.0) NA 4865 (16.8) NA 5756 (15.4) NA Both 44 586 (67.2) NA 20 315 (70.1) NA 24 271 (65.0) NA Clinical test Group; no. (%) of patients* Standardized difference (95% CI) All patients
n = 66 325Urban
n = 28 969Rural
n = 37 356HbA1c Test completed 51 007 (76.9) 22 085 (76.2) 28 922 (77.4) 0.028 (0.013 to 0.043) Result, %, mean ± SD† 7.35 ± 1.49 7.26 ± 1.50 7.41 ± 1.49 0.095 (0.077 to 0.113) Result on target† 26 157 (51.3) 11 877 (53.8) 14 280 (49.4) 0.088 (0.071 to 0.106) Low-density lipoprotein cholesterol Test completed 45 268 (68.3) 19 878 (68.6) 25 390 (68.0) 0.014 (−0.001 to 0.029) Result, mmol/L, mean ± SD† 2.41 ± 0.95 2.36 ± 0.94 2.46 ± 0.95 0.107 (0.088 to 0.126) Result on target† 17 175 (37.9) 8119 (40.8) 9056 (35.7) 0.107 (0.088 to 0.125) Urine albumin-to-creatinine ratio Test completed 22 676 (34.2) 10 148 (35.0) 12 528 (33.5) 0.031 (0.016 to 0.047) Result, mg/mmol, median (IQR)† 1.7 (0.8 to 5.4) 1.6 (0.8 to 5.1) 1.7 (0.8 to 5.6) 0.020 (−0.006 to 0.046) Result on target† 12 429 (54.8) 5708 (56.2) 6721 (53.6) 0.052 (0.026 to 0.078) Note: CI = confidence interval, HbA1c = glycated hemoglobin, IQR = interquartile range, SD = standard deviation.
↵* Except where indicated otherwise.
↵† Mean or median result and percentage on target were calculated in relation to number of patients with the particular test completed in the study period. Mean and median values were calculated using individuals’ most recent test results completed in the study period.
- Table 3:
Admission to hospital, by category of most responsible diagnosis
Reason for admission Group; no. (%) of patients Standardized difference (95% CI) All patients
n = 66 325Urban
n = 28 969Rural
n = 37 356Most responsible diagnosis (any)* 9079 (13.7) 3956 (13.7) 5123 (13.7) 0.002 (−0.014 to 0.017) Cardiovascular disease† 2299 (3.5) 1003 (3.5) 1296 (3.5) 0.0 (−0.015 to 0.016) Diabetes‡ 555 (0.8) 245 (0.8) 310 (0.8) 0.008 (−0.007 to 0.024) Renal disease§ 16 (< 0.1) 2 (< 0.1)¶ 14 (< 0.1) 0.021 (0.005 to 0.036) Note: CI = confidence interval.
↵* Includes all codes from the Canadian version of the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10-CA).
↵† Includes ICD-10-CA codes I00–I78 (e.g., ischemic heart disease, hypertensive disease, acute myocardial infarction, heart failure, stroke).
↵‡ Includes ICD-10-CA codes E10–E11 (type I diabetes – type II diabetes).
↵§ Includes ICD-10-CA codes N18–N19 (chronic kidney disease – unspecified kidney failure).
↵¶ The Fisher exact test was used because of the small sample size.